MSI Financial Services’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

MSI Financial Services’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$64K	Buy	3,470 +2,354	+211%	+$47K	﹤0.01%	1728
2016 Q3	$25K	Sell	1,116 -284	-20%	-$5.82K	﹤0.01%	2229
2016 Q2	$25K	Buy	1,400 +1,020	+268%	+$20K	﹤0.01%	2202
2016 Q1	$7K	Buy	380 +80	+27%	+$1.55K	﹤0.01%	2971
2015 Q4	$9K	Buy	+300	New	+$8.67K	﹤0.01%	2745

Other funds holding BBC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MSI Financial Services's BBC Position: Q4 2016 in Review

MSI Financial Services increased its Virtus Biotech Clinical Trials ETF (BBC) stake by 211% in Q4 2016, buying an estimated $47K and bringing the position to 3,470 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

MSI Financial Services first reported a position in BBC in Q4 2015 and has held it in 5 quarters since. 16 funds tracked by Wall St. Rank hold BBC as of Q4 2016.

MSI Financial Services held 3,470 shares of Virtus Biotech Clinical Trials ETF worth $64K as of Q4 2016.
MSI Financial Services bought 2,354 Virtus Biotech Clinical Trials ETF shares in Q4 2016, an estimated $47K.
Virtus Biotech Clinical Trials ETF made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1728 holding.
MSI Financial Services first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2015 and has held it in 5 quarters since.
16 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.